Volume 91, issue 1, Janvier 2004

Éditorial

Éditorial (p.7-8)
Paul Cappelaere

Synthèse

Frequency of cancer in France: 2004 update (p.9-14)
Catherine Hill, Françoise Doyon

RNA interference and its possible use in cancer therapy (p.15-8)
Slimane Ait‐Si‐Ali, Valentina Guasconi, Annick Harel‐Bellan

Recent advances in pharmacogenomics in oncology (p.19-28)
Jacques Robert, Jacques Bonnet

Cytogenetics, cytogenomics and cancer: 2004 update (p.29-43)
Alain Bernheim, Jean‐Louis Huret, Marine Guillaud‐Bataille, Olivier Brison, Jérôme Couturier et le Groupe français de cytogénétique oncologique

Optical diagnosis of cervical dysplasia (p.45-53)
Igor Charvet, Paolo Meda, Magalie Genet, Marie‐Françoise Pelte, Anne‐Thérèse Vlastos

Neoadjuvant endocrine therapy for breast cancer: an overview (p.55-62)
Julien Domont, Moise Namer, David Khayat, Jean‐Philippe Spano

Cyclooxygenase 2 and carcinogenesis (p.61-76)
Sylvie Rodrigues, Erik Bruyneel, Christelle M. Rodrigue, Emami Shahin, Christian Gespach

Adjuvant chemotherapy in non‐small cell lung cancer (p.63-7)
Laurent Taillade, Jean‐Charles Soria, Fabrice André, Dominique Grunenwald, Ariane Dunant, Jean‐Pierre Pignon, Thierry Le Chevalier

Hormone therapy for prostate cancer (p.69-74)
Christine Théodore

Colon cancer: what is new in 2004? (p.75-80)
Thierry André, Christophe Louvet, Aimery de Gramont

Cyclooxygenase 2 inhibitors and cancer chemoprevention (p.77-84)
Amine Masmoudi, Thierry Le Chevalier, Laure Sabatier, Jean‐Charles Soria

Radiosurgery of brain metastasis: reflexions, controversies and unanswered questions in 2004 (p.81-93)
Georges Noël, Gilbert Boisserie, Loïc Feuvret, Jean‐Jacques Mazeron

Cyclooxygenase 2 inhibitors and adenomatous polyposis coli (p.85-8)
Christian Florent, Nathalie Meary

Cyclooxygenase 2 inhibitors and colorectal cancer (p.89-98)
Marianne Bernardeau‐Mozer, Stanislas Chaussade

What‘s new in the treatment of cancer pain? (p.95-8)
Mario Di Palma, Philippe Poulain, Évelyne Pichard

Psycho‐oncology and the present tasks of psycho‐oncologists (p.99-104)
Daniel Oppenheim, Sarah Dauchy

Cyclooxygenase 2 and breast cancer (p.99-108)
Jean‐Paul Guastalla, Thomas Bachelot, Isabelle Ray‐Coquard

Cyclooxygenase 2 inhibitors and lung carcinoma (p.109-12)
Jean‐Philippe Spano, Kader Chouahnia, Jean‐François Morère

Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers (p.113-6)
Pascal Eschwege

Safety of the selective inhibitors the inducible cyclooxygenase-2 taken for long period (p.117-24)
Dominique Lamarque

Analgesic effects of cyclooxygenase 2 inhibitors (p.125-31)
Christian Jayr

COMPTE RENDU DE CONGRÈS

45 ^e congrès de l‘American Society of Therapeutic Radiology and Oncology (Astro) Salt Lake City, 19‐23 octobre 2003 (p.105-15)
Jean‐Jacques Mazeron, Séverine Racadot

Editorial

Inhibiteurs de la cyclo‐oxygénase 2 et cancer (p.59-60)
Thierry André, Jean‐Charles Soria